Merck & Co (MRK)
$89.38
0.00 (0.00%)
MRK Stock Quote Delayed 30 Minutes
7 Value Stocks To Buy in an Overvalued Market
While the coronavirus has brought excitement back to the markets, it’s the contrarian who is eyeballing value stocks that stands to win in the long run.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
226.25B
PE Ratio
13.28
EPS
6.73
Volume (Avg. Vol.)
218
Day's Range
-
52-Week Range
$81.04 - $134.63
Dividend & Yield
$3.08 (3.45%)
MRK Stock Predictions, Articles, and Merck & Co News
Merck Could Be the Covid-19 Investment You’re Missing
Some traders consider Merck stock to be a safe Dow Jones type of investment. Yet, the Covid-19 vaccine angle could propel the share price.
This Company is the Landlord of Life Sciences
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
Merck Stock Remains a Dull Biotech Play Despite Earnings Success
MRK stock isn't bad. It has a reasonable valuation, okay growth and a solid dividend. But Merck isn't my favorite pick in biotech.
Keytruda Powers a Stellar Q2 for Merck
Massive sales from the ever-so dependable Keytruda in the second quarter and aggressive actions make MRK stock a fabulous investment.
Merck Earnings: MRK Stock Pops 1% on Better-Than-Expected Q2
Merck (MRK) earnings for the pharmaceutical company's second quarter of 2020 have MRK stock up on Friday after beating estimates.
Avoid Merck Stock Until Shares Pull Back
Merck is a great company with a leading coronavirus vaccine candidate. Despite all that, upside is limited for MRK stock. Stay away.
Aggressive Investors Can Do Much Better Than Merck Stock
Merck stock has outperformed large-cap pharma stocks. But that's a low bar to clear, leaving investors with more attractive options elsewhere.
Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher
Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.
Dow Jones Today: More Bleak Jobs Data Didn’t Ding Stocks
In another instance of the market fighting off weak economic data, stocks rallied Thursday despite another spike in weekly jobless numbers.
Dow Jones Today: Stocks Swoon as the Fed Rejects Negative Rates
Stocks swooned Wednesday after Federal Reserve Chairman Jerome Powell said the novel coronavirus is creating lingering uncertainty for the U.S. economy while scoffing at the notion that negative interest rates could help the world's largest economy regain its footing.
Dow Jones Today: Stocks Sag Under Predictions Q2 Will Be Worst of 2020
The major equity averages didn't do much of anything Tuesday even as several big names reported earnings before the opening bell. Fortunately, there was some decent commentary from those companies, albeit cautious, indicating that the U.S. economy could start rebounding in the second half of the year.
Merck Earnings: Why MRK Stock Is 3% Lower Despite Q1 Beats
Merck (MRK) earnings for the pharmaceutical company's first quarter of 2020 have MRK stock falling Tuesday despite beating estimates.
3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb
Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.
7 Beautiful Biotech Stocks to Buy Here
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
This Stock Points to the Massive China Biotech Trend
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
3 Big Stock Charts for Wednesday: Coca-Cola, Mastercard, and Merck
Wednesday's big stock charts feature names that are preparing to meet with their significant support lines.
